Search

Katelyn Byrne, Ph.D.

Katelyn Byrne, Ph.D.

April 14, 2026

Katelyn Byrne, Ph.D., is senior author of a new OHSU study in the journal Immunity that identifies a potential path to making immunotherapy effective against pancreatic cancer. (OHSU/Christine Torres Hicks)

Katelyn Byrne Lab 2

Katelyn Byrne Lab 2

April 14, 2026

A pancreatic cancer cell slide on a microscope. Katelyn Byrne, Ph.D., is senior author of a new OHSU study in the journal Immunity that identifies a potential path to making immunotherapy effective against pancreatic cancer. (OHSU/Christine Torres Hicks)

Katelyn Byrne Lab 1

Katelyn Byrne Lab 1

April 14, 2026

From left: Katelyn Byrne, Ph.D., Margaret Haerr, Yi Zhang, and James Kim. (OHSU/Christine Torres Hicks)

Katelyn Byrne Lab

Katelyn Byrne Lab

April 14, 2026

Katelyn Byrne, Ph.D., es la autora sénior de un nuevo estudio de OHSU en la revista Immunity que identifica un posible camino para hacer que la inmunoterapia sea eficaz contra el cáncer de páncreas. (OHSU/Christine Torres Hicks)

Katelyn Byrne Lab 2

Katelyn Byrne Lab 2

April 14, 2026

Katelyn Byrne, Ph.D., es la autora sénior de un nuevo estudio de OHSU en la revista Immunity que identifica un posible camino para hacer que la inmunoterapia sea eficaz contra el cáncer de páncreas. (OHSU/Christine Torres Hicks)

Katelyn Byrne Lab 1

Katelyn Byrne Lab 1

April 14, 2026

Katelyn Byrne, Ph.D., es la autora sénior de un nuevo estudio de OHSU en la revista Immunity que identifica un posible camino para hacer que la inmunoterapia sea eficaz contra el cáncer de páncreas. (OHSU/Christine Torres Hicks)

See More Stories